African AIDS drug trial stopped prematurely By Dr Ananya Mandal.

African AIDS drug trial stopped prematurely By Dr Ananya Mandal, MD One of the studies in three African countries where ladies were given an AIDS medication to avoid HIV infection is being stopped because the project is not working, monday researchers said. These women on the trial were taking a daily dosage of the medication Truvada or a look-alike placebo tablet and had the same chance of becoming infected viagras . The types taking Truvada were likely to have got a much lower infection rate. The reason for the non-efficacy of the medication is not yet known. A study last year using it in homosexual men found that it reduced attacks by 44 %. Another study in which a similar medication was found in a vaginal gel decreased the HIV an infection rate in females by 39 %.

Since the start of the second one fourth, we have bought back approximately $96 million of our 3.5 percent convertible notes, strengthening our balance sheet and significantly reducing future interest obligations, stated Tim Barabe, executive vice CFO and president. Our balance sheet remains strong, with approximately $120 million in net cash, and we continue being cash-flow positive from procedures. Since the start of the second one fourth, the Company repurchased a complete of $95.8 million of its 3.5 percent convertible notes maturing in January 2013 for $88.9 million. During the second quarter, the Company repurchased $26.7 million of notes at face value for $24.6 million, and since June 30, 2010, it repurchased an additional $69.1 million face value of notes for $64.3 million.